Inventor · disambiguated record
Cavan Mckeon Bligh
Also filed as: BLIGH CAVAN MCKEON
4 granted patents·4 pending applications·52 citations·filing 2013–2023
74Inventor score
Top patents by PatentIndex Score
8 records- 0196US8895723B2Methods of preparing substituted nucleotide analogsALIOS BIOPHARMA INC·Filed 2013·Granted Nov 25, 2014·44 cites·20 claims
- 0291US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 0389US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 0479US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 0568US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0653US2023279010A1Processes for preparing modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0744US2019177295A1Process for the preparation of a 1,3-disubstituted pyrazole compoundVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 0842US2014309413A1Methods of stereoselective synthesis of substituted nucleoside analogsVERTEX PHARMA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cavan Mckeon Bligh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →